AlloSource Granted Sixth Patent For AlloTrue™, A Proprietary Tissue Cleaning and Disinfecting Process

News provided by

Dec 03, 2013, 09:00 ET

CENTENNIAL, Colo., Dec. 3, 2013 /PRNewswire-USNewswire/ --AlloSource (allosource.org), one of the nation's largest non-profit providers of skin, bone and soft tissue allografts for use in surgical procedures, and the world's largest processor of cellular bone allografts, has been awarded a patent for its propriety tissue cleaning and disinfecting system called AlloTrue. The patent title is Apparatus and methods for treating allograft products. This is the sixth patent in a family of patents protecting AlloSource's AlloTrue process and method.

AlloTrue is an innovative tissue cleaning and disinfecting system that uses rotation, coupled with sonication to effectively reduce bacteria. The technology works by exposing allografts to a variety of cleaning solutions inside a fully automated, closed, rotating canister. In addition to bacteria, AlloTrue removes the marrow and lipids that can be responsible for allograft discoloration.

"Garnering not one but an entire group of patents surrounding the AlloTrue system has been a lengthy process but an important and highly valuable one, due to the unique and pioneering nature of AlloTrue," said Thomas Cycyota, AlloSource President and CEO. "This exclusive method of cleaning transplantable tissues allows us to maximize each gift of life donated by generous tissue donors and their families. AlloTrue is also a testament to AlloSource's commitment to quality and improvement."

The first AlloTrue patent was issued February 9, 2010 and AlloSource has steadily devoted engineering talent to the technology's implementation and improvement since that time.

By focusing on quality, safety, service and a commitment to its mission, AlloSource has grown into one of the nations' largest non-profit bone, soft tissue and allograft skin networks in the country. The Company's safety and tissue processing standards meet and exceed guidelines set forth by the United States Food and Drug Administration (FDA) and the American Association of Tissue Banks (AATB).

About AlloSource
AlloSource is a non-profit company that offers more than 200 types of precise bone, skin, soft-tissue and custom-machined allografts for use in an array of life-saving and life-enhancing medical procedures. As the world's leader in fresh cartilage tissue used for joint repair and skin allografts to heal severe burns, AlloSource has grown into one of the largest tissue networks in the country with more than 400 employees. It is the world's largest processor of cellular bone allografts and delivers unparalleled expertise and customer service to its growing network of surgeons, partners and the country's most reputable organ procurement organizations. As one of the leading innovators in maximizing tissue donation with the goal of offering optimal solutions for healthcare providers and their patients, AlloSource is recognized by the medical community for its ability to process and provide high quality tissue. The company is accredited by the American Association of Tissue Banks and is headquartered in Centennial, CO. For more information, please visit allosource.org or our educational website, allograftpossibilities.org.

Media Contact
Colleen Kilkenny
AlloSource
720.382.2756
[email protected]

SOURCE AlloSource